RADX

Radiopharm Theranostics Ltd

4.340

+0.090+2.12%

Pre Market: 4.300 -0.040 -0.92%05:50 03/31 EDT

Daily

Weekly

Monthly

Quarterly

Yearly

OPEN/PREV CLOSE4.200/4.250

TODAY RANGE4.110-4.450

VOL2

MARKET CAP51.27M

52 WEEK RANGE3.496-16.25

AVG VOL (3M)171.09K

% TURNOVER0.60%

TURNOVER--

P/E (TTM)-1.4136

% RANGE8.00%

EPS(TTM)-3.0701

P/E(FORWARD)-1.3831

P/B1.484

BVPS2.925

DIVIDEND--

P/S14.33

BETA--

DIV YIELD0.00%

FREE FLOAT MKT CAP51.27M

SHARES OUTSTANDING11.81M

NEXT EARNINGS--

FREE FLOAT11.81M

LOT SIZE1

EX-DATE--

News

Press Releases

Financial Reports

Profile

TipRanks·3d ago
Biotech Alert: Searches spiking for these stocks today
TipRanks·3d ago
Radiopharm Theranostics Doses First Patient in Phase 1 RAD 402 Prostate Cancer Trial
Reuters·3d ago
Radiopharm Theranostics doses first patient in Phase 1 RAD 402 trial for advanced prostate cancer; data from first two dose levels expected in 2H 2026
TipRanks·4d ago
Buy Rating on RADX Driven by Promising RAD 101 Phase 2b Imaging Data and Clear 2026 Clinical Milestones
TipRanks·5d ago
Analysts Offer Insights on Healthcare Companies: Radiopharm Theranostics Limited Sponsored ADR (RADX), Alnylam Pharma (ALNY) and Fractyl Health, Inc. (GUTS)
Reuters·6d ago
RADIOPHARM THERANOSTICS ACHIEVES PRIMARY ENDPOINT IN 90% OF PATIENTS AT SECOND INTERIM ANALYSIS OF RAD 101 PHASE 2B IMAGING TRIAL IN BRAIN METASTASES
Reuters·6d ago
Radiopharm reports 90% primary-endpoint concordance in second interim analysis of RAD 101 Phase 2b brain metastases imaging trial
Reuters·6d ago
Radiopharm reports 90% RAD 101 PET-MRI concordance in interim Phase 2b brain metastases trial
Reuters·03/19 10:23
Radiopharm Theranostics to present at NWR Virtual Healthcare Conference
Reuters·03/18 12:56
Radiopharm Theranostics Ltd. Director Bruce Michael Goodwin Files Initial Beneficial Ownership Statement
Seeking Alpha·03/11 22:29
Radiopharm: 'Hold' As Theranostics Pipeline Has Several 2026 Milestones
Reuters·03/10 17:45
Radiopharm Theranostics publishes corporate presentation on its radiopharmaceutical theranostics pipeline and clinical trials
TipRanks·03/06 16:31
Analysts Are Bullish on These Healthcare Stocks: Schrodinger (SDGR), Radiopharm Theranostics Limited Sponsored ADR (RADX)
Reuters·02/25 19:50
Radiopharm Theranostics doses first patient in Phase 1/2a trial of 177Lu-BetaBart (RV-01)

Same Industry

Name/Symbol

Change%

Price

MCK

BIIB

AMGN

SHPG

Bristol-Myers Squibb Company Celegne Contingent Value Rights

CELG-RT

+0.40%

0.1005

Lilly Eli & Co

LLY

-2.09%

878.24

CELG

TXMD

Johnson & Johnson

JNJ

+0.51%

240.45

ABBV

Zoetis Inc

ZTS

+2.63%

116.33

Gilead Sciences Inc

GILD

-1.92%

134.25

NVO

BMY

ALXN

Pfizer

PFE

-1.92%

27.04

Sanofi FR

SNY

+0.34%

46.78

GCVRZ

Novartis

NVS

-1.02%

148.18

RDY

No content on the Webull website shall be considered a recommendation or solicitation for the purchase or sale of securities, options or other investment products. All information and data on the website is for reference only and no historical data shall be considered as the basis for judging future trends.